Lisata Therapeutics
Stock Forecast, Prediction & Price Target
Lisata Therapeutics Financial Estimates
Lisata Therapeutics Revenue Estimates
Lisata Therapeutics EBITDA Estimates
Lisata Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $121.37M 0% | $0 -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $7.2M Low: $7.2M High: $7.2M avg. 0% |
Net Income
% change YoY
| $-27.46M N/A | $-54.22M -97.42% | $-20.84M 61.56% | Avg: $-30.02M Low: $-24.54M High: $-18.81M avg. -44.09% | Avg: $-28.3M Low: $-13.56M High: $-13.56M avg. 5.75% | Avg: $-14.45M Low: $-14.45M High: $-14.45M avg. 48.93% | Avg: $-13.48M Low: $-13.48M High: $-13.48M avg. 6.70% |
EBITDA
% change YoY
| $-29.14M N/A | $-58.58M -101.00% | $-25.51M 56.44% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $5.06M Low: $5.06M High: $5.06M avg. 0% |
EPS
% change YoY
| -$7.45 N/A | -$10.47 -40.53% | -$2.58 75.35% | Avg: -$2.69 Low: -$3.04 High: -$2.33 avg. -4.06% | Avg: -$1.68 Low: -$1.68 High: -$1.68 avg. 37.43% | Avg: -$1.79 Low: -$1.79 High: -$1.79 avg. -6.54% | Avg: -$1.67 Low: -$1.67 High: -$1.67 avg. 6.70% |
Operating Expenses
% change YoY
| $29.05M N/A | $57.60M 98.28% | $25.70M -55.36% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $5.92M Low: $5.92M High: $5.92M avg. 0% |
FAQ
What is Lisata Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 4.32% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -24.54M, average is -30.02M and high is -18.81M.
What is Lisata Therapeutics stock revenue growth forecast?
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Lisata Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 8.37% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$3.04, average is -$2.69 and high is $-2.33.